Azacitidine for the treatment of patients with acute myeloid leukemia-Reference-Cited by-同舟云学术

Azacitidine for the treatment of patients with acute myeloid leukemia

Published:2011-07-14 Issue:4 Volume:118 Page:1014-1022
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Maurillo Luca,Venditti Adriano,Spagnoli Alessandra,Gaidano Gianluca,Ferrero Dario,Oliva Esther,Lunghi Monia,D'Arco Alfonso M.,Levis Alessandro,Pastore Domenico,Di Renzo Nicola,Santagostino Alberto,Pavone Vincenzo,Buccisano Francesco,Musto Pellegrino

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.26354/fullpdf

Reference46 articles.

1. Acute myeloid leukemia;Lowenberg;N Engl J Med.,1999

2. On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group;Lowenberg;J Clin Oncol.,1989

3. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy: a Southwest Oncology Group study;Leith;Blood.,1997

4. Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial;Goldstone;Blood.,2001

5. Acute myeloid leukemia and myelodysplastic syndromes in older patients;Estey;J Clin Oncol.,2007

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DUSP5 regulated by YTHDF1-mediated m6A modification promotes epithelial-mesenchymal transition and EGFR-TKI resistance via the TGF-β/Smad signaling pathway in lung adenocarcinoma;Cancer Cell International;2024-06-13

2. Decitabine as epigenetic priming with CLAG induce improved outcome of relapsed or refractory acute myeloid leukemia in children;Clinical Epigenetics;2024-05-09

3. What’s Next after Hypomethylating Agents Failure in Myeloid Neoplasms? A Rational Approach;Cancers;2023-04-12

4. Comparison between azacitidine and decitabine as front-line therapy in elderly acute myeloid leukemia patients not eligible for intensive chemotherapy;Leukemia Research;2023-04

5. Acute Myeloid Leukemia Treatment in the Elderly: A Comprehensive Review of the Present and Future;Acta Haematologica;2023